Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Leonard Schleifer
Pharma
Regeneron's Eylea franchise stumbles on several fronts in Q1
After consecutive setbacks at the FDA, Regeneron's string of recent troubles with its Eylea franchise is continuing to pull down the drugmaker.
Fraiser Kansteiner
Apr 29, 2025 2:50pm
With $453M, Regeneron's Schleifer tops biopharma's realized pay
Jul 18, 2022 11:17am
Shareholder groups target Regeneron's CEO, CSO compensation
Jun 9, 2021 11:13am
Lower Libtayo's price before Chinese PD-1s do, says analyst
Apr 20, 2021 10:15am
Regeneron’s Science Talent Search names 40 student finalists
Feb 8, 2021 10:45am
Regeneron CEO, CSO could nab $713M bonuses—if the pipeline pays
Jan 6, 2021 11:40am
